Chicago, Illinois--(Newsfile Corp. - October 19, 2021) - According to the new market research report "Epilepsy Monitoring Devices Market by Product (Conventional & Wearable Devices, Standard EEG, Video EEG, Ambulatory EEG, EMG, MEG, Deep Brain Stimulation Devices) End User (Hospitals, Neurology Centres, ASC, Home Care Settings) - Global Forecast to 2026", published by MarketsandMarkets, the Epilepsy Monitoring Devices Market is projected to reach USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7% during the forecast period.
Browse in-depth TOC on "Epilepsy Monitoring Devices Market"
130 - Tables
43 - Figures
187 - Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62758189
The growth of this Epilepsy monitoring devices is majorly attributed to the increasing incidence and prevalence of epilepsy, growing preference for ambulatory healthcare and increasing use of wearables, growing demand for continuous monitoring, and the rising awareness of neurodegenerative diseases, including epilepsy. On the other hand, the high cost of complex epilepsy monitoring procedures and devices and the unfavorable reimbursement policies are restraining the growth of this market.
By product type segment, the conventional devices segment accounted for the largest market share during the forecast period.
Based on products, the epilepsy monitoring devices market has been segmented into wearable devices and conventional devices. The factors attributing to the large revenue of the conventional devices segment include the increasing incidence of epilepsy, especially in developing countries, and rising awareness about neurodegenerative diseases like epilepsy among the population.
Monitoring devices accounted for the largest market share in the conventional devices segment during the forecast period.
In the conventional devices segment, monitoring devices accounted for the largest market share during the forecast period. This can be attributed to the increasing demand for continuous, non-invasive monitoring of epilepsy and the application of these devices in other areas of neurology.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=62758189
North America dominates the epilepsy monitoring devices market during the forecast period.
North America accounted for the largest share of the market in 2020. The high incidence of neurological disorders, a growing number of clinical trials for epilepsy monitoring devices, and a large number of end users in the US are the major factor contributing to this.
The major players in the global epilepsy monitoring devices market include Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Drägerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia), Advanced Brain Monitoring (US), Lifelines Neuro Company, LLC (US), Mitsar Co., Ltd. (Russia), Rimed (US), Emotiv (US), CGX (A Cognionics Company) (US), Mindray Medical International Ltd. (China), Cadwell Industries, Inc. (US), NeuroWave Systems, Inc. (US), and MC10, Inc. (US).
Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=62758189
About MarketsandMarkets
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/epilepsy-monitoring-devices.asp
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/100152
